These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20048394)

  • 21. Long-term clinical outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry.
    Sousa A; Costa JR; Moreira AC; Cano M; Maldonado G; Costa RA; Pavanello R; Romano ER; Campos C; Haddad N; Abizaid A; Feres F; Mattos LA; Staico R; Sousa JE;
    J Interv Cardiol; 2008 Aug; 21(4):307-14. PubMed ID: 18754966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety of drug-eluting stents.
    Saia F; Marzocchi A; Branzi A
    Ther Adv Cardiovasc Dis; 2008 Feb; 2(1):43-52. PubMed ID: 19124407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents.
    Doyle B; Rihal CS; O'Sullivan CJ; Lennon RJ; Wiste HJ; Bell M; Bresnahan J; Holmes DR
    Circulation; 2007 Nov; 116(21):2391-8. PubMed ID: 17984377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of the 2006 Food and Drug Administration Circulatory System Devices Panel meeting on drug-eluting stent thrombosis.
    Pinto Slottow TL; Waksman R
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):1064-74. PubMed ID: 17525967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Rossini R; Musumeci G; Aprile A; Valsecchi O
    Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):49-61. PubMed ID: 20121564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease.
    Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
    Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and safety of implantation of multiple drug-eluting stents].
    Fu Q; Li ZL; Wu HC
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):110-2. PubMed ID: 18227039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?].
    Okmen AS; Okmen E
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):325-30. PubMed ID: 19666436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
    Newsome LT; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On registries and labels.
    Murray SW; Ramsdale D
    J Invasive Cardiol; 2010 Feb; 22(2):56. PubMed ID: 20124587
    [No Abstract]   [Full Text] [Related]  

  • 33. Mounting evidence for safety and improved outcomes of drug-eluting stenting: but is it the stent?
    King SB; Hannan EL
    Circulation; 2008 Oct; 118(18):1783-4. PubMed ID: 18852362
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations.
    Paradis JM; Ducrocq G; Tanguay JF
    Minerva Cardioangiol; 2008 Feb; 56(1):139-54. PubMed ID: 18432176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
    Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J
    J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
    Kumbhani DJ; Bavry AA; Bhatt DL
    Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
    Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S;
    J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
    Bavry AA; Kumbhani DJ; Helton TJ; Bhatt DL
    J Am Coll Cardiol; 2005 Mar; 45(6):941-6. PubMed ID: 15766833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of early discontinuation of dual-antiplatelet therapy: room for improvement.
    Jarvie JL; Foody JM
    Circulation; 2010 Sep; 122(10):946-8. PubMed ID: 20733094
    [No Abstract]   [Full Text] [Related]  

  • 40. Stent-related cardiac events after non-cardiac surgery: drug-eluting stent vs. bare metal stent.
    Kim HL; Park KW; Kwak JJ; Kim YS; Sir JJ; Lee SJ; Lee HY; Chang HJ; Kang HJ; Cho YS; Chung WY; Chae IH; Choi DJ; Kim HS; Oh BH; Park YB; Koo BK
    Int J Cardiol; 2008 Jan; 123(3):353-4. PubMed ID: 17346821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.